This study is looking at whether The first phase is a multi-centre, open-label, safety, tolerability and dose-finding study of cannabidiol (CBD) can help people with Parkinson’s disease psychosis, Mental and Behavioural Disorders, or Parkinson disease. Participants receive a study treatment and complete follow-up visits and assessments.
In United Kingdom
Why is this study shown?
This study is directly about Schizophrenia.
SchizophreniaOtherFrom 40 Years to 99 Years
Countries
United Kingdom
Sponsor
King’s College London and South London & Maudsley NHS Foundation Trust
This study is looking at whether cognitive behavioural therapy can help people with Psychosis or Mental and Behavioural Disorders. Participants take part in cognitive behavioural therapy and complete follow-up assessments.
This study is looking at whether cognitive behavioural therapy can help people with PTSD, schizophrenia, psychosis or Mental and Behavioural Disorders. Participants take part in the therapy or support program and complete follow-up questionnaires or assessments.
In United Kingdom
Why is this study shown?
This study is directly about Schizophrenia.
Schizophrenia, PTSDOtherFrom 18 Years to 110 Years
This study is looking at whether a digital support tool can help people with Psychosis, Mental and Behavioural Disorders, or Unspecified nonorganic psychosis. Participants take part in the program and complete follow-up questionnaires or assessments.
This observational study is following people with Early Identification of people at risk of psychosis in Primary Care Services or Mental and Behavioural Disorders to understand outcomes over time. Participants mainly provide questionnaire, assessment, or follow-up information rather than receiving a new study treatment.
This study is looking at care and outcomes for people with Psychosis or Mental and Behavioural Disorders. Taking part may give some people access to a digital support tool, but direct benefit is not guaranteed.
This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.
In Spain
Why is this study shown?
This study is directly about Schizophrenia.
SchizophreniaDrugA study involving a medication or substance.
This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.
This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.
HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.
